NCT02058264View on ClinicalTrials.gov

A Safety, Tolerability and Preliminary Efficacy Study of BBI-4000 in Subjects With Axillary Hyperhidrosis

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

August 31, 2014

Study Completion Date

September 30, 2014

Conditions
Hyperhidrosis
Interventions
DRUG

BBI-4000

Sponsors
All Listed Sponsors
lead

Botanix Pharmaceuticals

INDUSTRY